Transfusion Medicine

Quotient Biodiagnostics Signs Agreement With Carter Bloodcare To Become Main Supplier of Manual Transfusion Diagnostics Products

Published in Blood Weekly, March 11th, 2010

Quotient Biodiagnostics, Inc., announced that it has entered into a 3-year agreement with Carter BloodCare to become the Center's main supplier of traditional transfusion diagnostics products. The deal will include Quotient's first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics as well as future products, as they become FDA approved and available.

Founded in 1998 by the merger of two local blood centers, Carter BloodCare has grown to become Texas' largest blood center, providing more than 330,000 units of lifesaving blood to North, Central and East Texas each year.

"We are exceptionally pleased that Carter BloodCare...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2010-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry